Recent Price Movement and Market Context
National Peroxide’s stock hit a new 52-week and all-time low of ₹441.1 during intraday trading on 05-Jan, marking a significant downturn. The stock underperformed its sector by 5.43% on the day and reversed a four-day streak of consecutive gains. Notably, the weighted average price indicates that a larger volume of shares traded closer to the day’s low, signalling selling pressure. The stock is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically suggests a bearish trend.
In comparison to the broader market, National Peroxide has lagged considerably. Over the past week, the stock declined by 4.32%, while the Sensex rose by 0.88%. The one-month performance shows a 10.69% drop for the stock against a marginal 0.32% decline in the Sensex. Year-to-date, the stock is down 4.55%, whereas the benchmark index has gained 0.26%. Most strikingly, over the last year, National Peroxide’s shares have plummeted by 46.44%, in stark contrast to the Sensex’s 7.85% gain. This persistent underperformance highlights investor concerns about the company’s prospects.
Transformation in full progress! This Micro Cap from Auto Ancillary just achieved sustainable profitability after tough times. Be early to witness this powerful comeback story!
- - Sustainable profitability reached
- - Post-turnaround strength
- - Comeback story unfolding
Fundamental Weaknesses Weighing on the Stock
The decline in National Peroxide’s share price is underpinned by weak long-term fundamentals. The company has experienced a negative compound annual growth rate (CAGR) of -135.58% in operating profits over the past five years, indicating a severe erosion of core earnings. This poor profitability is further reflected in the company’s average return on equity (ROE) of just 1.90%, signalling limited returns generated for shareholders relative to their invested capital.
Debt servicing capacity is another area of concern. The company’s average EBIT to interest ratio stands at a low 0.14, suggesting that earnings before interest and tax are insufficient to comfortably cover interest expenses. This weak coverage ratio raises questions about financial stability and increases risk for investors.
Recent financial results have also disappointed. The latest six-month profit after tax (PAT) was ₹1.28 crore, representing a decline of 77.78%. Moreover, non-operating income accounted for an outsized 263.49% of profit before tax, indicating that core business operations are not generating sustainable profits and that earnings are being propped up by irregular income sources.
Risk and Valuation Concerns
National Peroxide’s stock is considered risky relative to its historical valuations. Over the past year, the stock’s price has fallen by nearly half, while profits have contracted by 113%, underscoring the disconnect between market value and financial performance. This negative trajectory has led to the stock underperforming not only the Sensex but also the broader BSE500 index over multiple time frames, including one year, three months, and three years.
Investor participation has increased recently, with delivery volumes rising by 43.56% on 02 Jan compared to the five-day average. However, this heightened activity has coincided with further price declines, suggesting that selling pressure may be intensifying rather than abating.
Holding National Perox. from Commodity Chemicals? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Conclusion: Why the Stock is Falling
National Peroxide Ltd’s share price decline on 05-Jan is a reflection of its deteriorating financial health, poor profitability metrics, and sustained underperformance relative to market benchmarks. The stock’s breach of key technical support levels and trading below all major moving averages further compounds bearish sentiment. Despite increased investor activity, the lack of positive earnings growth and weak debt servicing ability continue to weigh heavily on the stock’s valuation.
For investors, these factors suggest caution, as the company faces significant challenges in reversing its downward trend. The stock’s current trajectory is unlikely to improve without a meaningful turnaround in operational performance and profitability.
Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →
